Literature DB >> 20670649

Severe, critical and fatal cases of 2009 H1N1 influenza in China.

Peng Yang1, Ying Deng, Xinghuo Pang, Weixian Shi, Xinyu Li, Lili Tian, Yi Zhang, Xiaoli Wang, Fang Huang, Macintyre C Raina, Quanyi Wang.   

Abstract

OBJECTIVE: For severe, critical and fatal cases of 2009 H1N1 influenza in the winter in the Northern Hemisphere, the detailed features are not fully known. The aim of this study was to examine these features through describing these cases in Beijing, China in 2009.
METHODS: Data on severe, critical and fatal cases were collected via the Notifiable Disease Surveillance System and a designated surveillance system for managing 2009 H1N1 influenza cases in Beijing. The characteristics and risk factors of these cases were elucidated.
RESULTS: A total of 475 severe cases, 73 critical ones and 69 deaths were identified in 2009. The proportion of obesity was low, as well as pregnancy. About half of them had no underlying disease. Most of deaths had multi-organ failure, with a median interval from illness onset to death of ten days. Delay in visiting hospital, cardiovascular disease and allergy predicted a higher risk of severe disease, and cases aged 6-17 years were at lower risk. Cases not promptly receiving neuraminidase inhibitors were at increased risk of death.
CONCLUSIONS: Age and underlying disease are significantly associated with severity of outcomes of 2009 H1N1 influenza; prompt presentation to hospital and use of neuraminidase inhibitor were protective.
Copyright © 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670649     DOI: 10.1016/j.jinf.2010.07.010

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  18 in total

Review 1.  Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies.

Authors:  Zhengtu Li; Li Li; Shuai Zhao; Jing Li; Hongxia Zhou; Yunhui Zhang; Zifeng Yang; Bing Yuan
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 2.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

3.  Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Authors:  Peng Yang; Li Zhang; Weixian Shi; Guilan Lu; Shujuan Cui; Xiaomin Peng; Daitao Zhang; Yimeng Liu; Huijie Liang; Xinghuo Pang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2011-12-30       Impact factor: 4.380

Review 4.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Pandemic (H1N1) 2009 among quarantined close contacts, Beijing, People's Republic of China.

Authors:  Xinghuo Pang; Peng Yang; Shuang Li; Li Zhang; Lili Tian; Yang Li; Bo Liu; Yi Zhang; Baiwei Liu; Ruogang Huang; Xinyu Li; Quanyi Wang
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

Review 6.  Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection.

Authors:  Noboru Uchide; Kunio Ohyama; Toshio Bessho; Makoto Takeichi; Hiroo Toyoda
Journal:  Mediators Inflamm       Date:  2012-07-31       Impact factor: 4.711

7.  Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.

Authors:  Maria D Van Kerkhove; Katelijn A H Vandemaele; Vivek Shinde; Giovanna Jaramillo-Gutierrez; Artemis Koukounari; Christl A Donnelly; Luis O Carlino; Rhonda Owen; Beverly Paterson; Louise Pelletier; Julie Vachon; Claudia Gonzalez; Yu Hongjie; Feng Zijian; Shuk Kwan Chuang; Albert Au; Silke Buda; Gerard Krause; Walter Haas; Isabelle Bonmarin; Kiyosu Taniguichi; Kensuke Nakajima; Tokuaki Shobayashi; Yoshihiro Takayama; Tomi Sunagawa; Jean Michel Heraud; Arnaud Orelle; Ethel Palacios; Marianne A B van der Sande; C C H Lieke Wielders; Darren Hunt; Jeffrey Cutter; Vernon J Lee; Juno Thomas; Patricia Santa-Olalla; Maria J Sierra-Moros; Wanna Hanshaoworakul; Kumnuan Ungchusak; Richard Pebody; Seema Jain; Anthony W Mounts
Journal:  PLoS Med       Date:  2011-07-05       Impact factor: 11.069

8.  When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto.

Authors:  Stefan P Kuster; Kevin C Katz; Joanne Blair; James Downey; Steven J Drews; Sandy Finkelstein; Rob Fowler; Karen Green; Jonathan Gubbay; Kazi Hassan; Stephen E Lapinsky; Tony Mazzulli; Donna McRitchie; Janos Pataki; Agron Plevneshi; Jeff Powis; David Rose; Alicia Sarabia; Carmine Simone; Andrew Simor; Allison McGeer
Journal:  Crit Care       Date:  2011-07-28       Impact factor: 9.097

9.  Risk Factors for influenza A(H1N1)pdm09 among students, Beijing, China.

Authors:  Yang Zheng; Wei Duan; Peng Yang; Yi Zhang; Xiaoli Wang; Li Zhang; Surabhi S Liyanage; Quanyi Wang
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

10.  Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.

Authors:  Paula E Miller; Aksharananda Rambachan; Roderick J Hubbard; Jiabai Li; Alison E Meyer; Peter Stephens; Anthony W Mounts; Melissa A Rolfes; Charles R Penn
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.